BCHE and early-onset autosomal dominant Alzheimer disease: These cholinesterases can also be inhibited in a pseudo-irreversible manner, through a covalent bond between the inhibitor and the enzymes, as is the case with rivastigmine, which is currently also used against Alzheimer’s disease (Figure 6).